Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® Endonuclease PR Newswire Innovative Solutions Optimize the Harvest Process in Gene Therapy Manufacturing Sustainably and at Scale RADNOR, Pa. , July 1, 2024 /PRNewswire/ -- Av...

SYDNEY, July 01, 2024 (GLOBE NEWSWIRE) -- IREN (Iris Energy Limited) (NASDAQ: IREN ) (together with its subsidiaries, "IREN" or “the Company”), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today provided a business update. ...

Stellantis to Announce First Half 2024 Results on July 25 AMSTERDAM, July 1, 2024 - Stellantis N.V. announced today that its First Half 2024 Results will be released on Thursday, July 25, 2024. A live webcast and conference call of the First Half 2024 Results will begin at 2:00 ...

Stellantis to Announce First Half 2024 Results on July 25 AMSTERDAM, July 1, 2024 - Stellantis N.V. announced today that its First Half 2024 Results will be released on Thursday, July 25, 2024. A live webcast and conference call of the First Half 2024 Results will begin at 2:00 ...

First non-Bentley family member to lead company, Cumins unveils vision for infrastructure resilience powered by AI, focus on operations phase of lifecycle Following the CEO transition plan previously announced by Bentley Systems, Incorporated (Nasdaq: BSY), Nicholas Cumins today takes c...

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex PR Newswire WASHINGTON , July 1, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. District Court for the District of ...

MEDIA ALERT: Equinix Sets Conference Call for Second-Quarter PR Newswire REDWOOD CITY, Calif. , July 1, 2024 /PRNewswire/ -- Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company ® , today announced that it will hold its quarterly ...

Builds on U.S. biosimilar portfolio of seven products with three commercial and four in pipeline 8 th biosimilar expands portfolio into allergy treatments, a new therapeutic area Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Companyȁ...

Builds on successful U.S. biosimilar partnership of 2 oncology products (RELEUKO ® & FYLNETRA ® ) ADL018 is Kashiv’s lead pipeline biosimilar program, currently in Phase III Kashiv BioSciences, LLC (“Kashiv” or the “Companyȁ...

ATHENS, Greece, July 01, 2024 (GLOBE NEWSWIRE) -- TEN, Ltd. (the “Company”), a leading diversified crude, product, and LNG tanker operator, would like to remind its shareholders and the investing public of the new ticker symbol that comes into effect today. As such, the Company ...